Trials / Completed
CompletedNCT00668343
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 15 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Patient with relapsing remitting multiple sclerosis taking avonex are included in this double blind randomized control trial. Simvastatin is compared to placebo. end points of edss , total attack, new enhancing lesion and newt2 lesion in mri is evaluated as end point.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | simvastatin | 40 mg/ day |
| DRUG | placebo | 80 mg /day |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2008-03-01
- Completion
- 2009-03-01
- First posted
- 2008-04-29
- Last updated
- 2010-07-30
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00668343. Inclusion in this directory is not an endorsement.